Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseaseJing Fu, Suzanne Lentzsch|Journal of Clinical Investigation|2016Cited by 73
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone diseaseJing Fu, Suzanne Lentzsch|Nature Communications|2023Cited by 19